Patent · US Active

Assay for detecting hepatitis C virus (HCV)

US11021763B2 · kind B2 · utility

0Cited by

4References

19Claims

0Family size

Assignee

Abbott Molecular Inc. · US

Inventors

Dan Toolsie · Des Plaines, US
Shihai Huang · Des Plaines, US
Hong Su · Evanston, US
Darren Drapp · Des Plaines, US
William Caminiti · Des Plaines, US
Kara Nordin · Des Plaines, US
Sevim Arslan · Des Plaines, US
Sara Jones · Des Plaines, US

Key dates

Filing date	Oct 3, 2018
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Jun 3, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/166
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The disclosure is directed to methods, kits, and compositions, for amplifying and detecting a human hepatitis C virus (HCV) in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.